Analyze Diet
American journal of veterinary research2004; 65(1); 110-115; doi: 10.2460/ajvr.2004.65.110

Expression of bone morphogenetic protein-6 and -2 and a bone morphogenetic protein antagonist in horses with naturally acquired osteochondrosis.

Abstract: To determine the mRNA expression of bone morphogenetic protein (BMP)-6 and -2 and a BMP antagonist (Noggin) in horses with osteochondrosis. Methods: Samples of articular cartilage from affected stifle or shoulder joints of 10 immature horses with naturally acquired osteochondrosis and corresponding joints of 9 clinically normal horses of similar age; additionally, samples of distal femoral growth plate cartilage and distal femoral articular cartilage were obtained from a normal equine fetus. Methods: Cartilage specimens were snap-frozen in liquid nitrogen, and total RNA was isolated. Adjacent specimens were fixed in 4% paraformaldehyde for histologic examination. Expression of BMP-6, BMP-2, and Noggin mRNA was evaluated by real-time quantitative polymerase chain reaction (PCR) assays. Spatial tissue mRNA expression of BMP-6 was determined by in situ hybridization. Results: Nucleotide sequences were obtained for portions of the BMP-6 propeptide and mature peptide region, as well as the signal and mature peptide region of Noggin. Expression of BMP-6, BMP-2, and Noggin mRNA was found to be similar in cartilage from normal and osteochondrosis-affected horses. Spatial expression of BMP-6 correlated with the middle and deep layers of articular cartilage; no differences were observed in overall expression between cartilage specimens from the 2 groups of horses. No expression of BMP-6 was found in the superficial layer, subchondral bone, or osteochondrosis-affected cleft fibrous tissue. Conclusions: Although these signaling peptides may play important roles in cartilage differentiation, results did not provide evidence to suggest that they are involved in the disease process of osteochondrosis.
Publication Date: 2004-01-15 PubMed ID: 14719712DOI: 10.2460/ajvr.2004.65.110Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research sought to understand the expression levels of bone morphogenetic proteins (BMPs) 6 and 2, as well as an antagonist called Noggin, in horses afflicted with a joint condition called osteochondrosis. The study found that these proteins’ expression levels were similar in both normal horses and those affected by osteochondrosis, implying that these proteins may not have a significant role in the disease process.

Methodology

  • The researchers gathered samples of articular cartilage from 10 young horses with osteochondrosis and 9 similarly aged, healthy horses for comparison. They also obtained samples from a normal equine fetus.
  • The cartilage samples were snap-frozen in liquid nitrogen to preserve them, and total RNA was extracted for analysis.
  • To test for levels of the BMP-6, BMP-2, and Noggin proteins, the researchers used real-time quantitative polymerase chain reaction (PCR) assays. This technique allows for the tracking of the growth of particular DNA sequences in real-time, providing data on their starting concentrations in the sample.
  • In addition to PCR, in-situ hybridization was used to understand BMP-6’s spatial expression within tissue.

Findings

  • Nucleotide sequences were successfully extracted for portions of the BMP-6 propeptide, the mature peptide region, and the signal and mature peptide region of Noggin.
  • No substantial difference was found in the expression of BMP-6, BMP-2, and Noggin mRNA between normal and osteochondrosis-affected horses. Thus, these proteins may not be implicated in the progression of osteochondrosis, despite potentially playing important roles in cartilage differentiation.
  • Spatial analysis of BMP-6 expression demonstrated correlation with the middle and deep layers of articular cartilage. The superficial layer, subchondral bone, or fibrous tissue affected by osteochondrosis showed no presence of BMP-6.

Conclusions

  • The similar protein expression rates in healthy and osteochondrosis-affected horses indicate that BMP-6, BMP-2, and Noggin, while likely playing significant roles in cartilage differentiation, may not be involved in the disease process of osteochondrosis.
  • Further research is required to investigate other potential players in the onset and progression of osteochondrosis in horses.

Cite This Article

APA
Semevolos SA, Nixon AJ, Strassheim ML. (2004). Expression of bone morphogenetic protein-6 and -2 and a bone morphogenetic protein antagonist in horses with naturally acquired osteochondrosis. Am J Vet Res, 65(1), 110-115. https://doi.org/10.2460/ajvr.2004.65.110

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 65
Issue: 1
Pages: 110-115

Researcher Affiliations

Semevolos, Stacy A
  • Comparative Orthopaedics Laboratory, Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Nixon, Alan J
    Strassheim, M Lisa

      MeSH Terms

      • Animals
      • Base Sequence
      • Bone Morphogenetic Protein 2
      • Bone Morphogenetic Protein 6
      • Bone Morphogenetic Proteins / antagonists & inhibitors
      • Bone Morphogenetic Proteins / genetics
      • Carrier Proteins
      • DNA Primers
      • Horse Diseases / genetics
      • Horses
      • In Situ Hybridization
      • Molecular Sequence Data
      • Osteochondritis / genetics
      • Osteochondritis / veterinary
      • Polymerase Chain Reaction
      • Proteins / genetics
      • RNA, Messenger / genetics
      • Sequence Analysis, DNA
      • Sequence Homology
      • Transforming Growth Factor beta

      Citations

      This article has been cited 1 times.
      1. Cheng C, Conte E, Pleshko-Camacho N, Hidaka C. Differences in matrix accumulation and hypertrophy in superficial and deep zone chondrocytes are controlled by bone morphogenetic protein. Matrix Biol 2007 Sep;26(7):541-53.
        doi: 10.1016/j.matbio.2007.05.006pubmed: 17618099google scholar: lookup